DK1729735T3 - Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved - Google Patents
Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet dervedInfo
- Publication number
- DK1729735T3 DK1729735T3 DK04810659T DK04810659T DK1729735T3 DK 1729735 T3 DK1729735 T3 DK 1729735T3 DK 04810659 T DK04810659 T DK 04810659T DK 04810659 T DK04810659 T DK 04810659T DK 1729735 T3 DK1729735 T3 DK 1729735T3
- Authority
- DK
- Denmark
- Prior art keywords
- dosage forms
- solid dosage
- compressed solid
- preparation
- water solubility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/037462 WO2006052254A2 (en) | 2004-11-10 | 2004-11-10 | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1729735T3 true DK1729735T3 (da) | 2007-10-08 |
Family
ID=36218312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04810659T DK1729735T3 (da) | 2004-11-10 | 2004-11-10 | Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1729735B1 (pt) |
JP (1) | JP4842960B2 (pt) |
AT (1) | ATE365546T1 (pt) |
AU (1) | AU2004324858B2 (pt) |
CA (1) | CA2587295A1 (pt) |
DE (1) | DE602004007302T2 (pt) |
DK (1) | DK1729735T3 (pt) |
HK (1) | HK1096875A1 (pt) |
IL (2) | IL182549A (pt) |
PT (1) | PT1729735E (pt) |
WO (1) | WO2006052254A2 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2242483B1 (en) * | 2007-12-21 | 2013-02-20 | Synthon B.V. | Raloxifene composition |
US20110159084A1 (en) * | 2008-04-02 | 2011-06-30 | Dr. Reddy's Laboratories Ltd. | Raloxifene pharmaceutical formulations |
WO2011000581A2 (en) | 2009-07-02 | 2011-01-06 | Synthon B.V. | Raloxifene composition |
EP3650010B1 (en) * | 2018-11-09 | 2021-01-06 | Siegfried AG | Improved tableting process |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
US5478847A (en) * | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
KR100405116B1 (ko) * | 1995-02-28 | 2004-02-05 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올화합물에대한약제학적조성물 |
IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
CN1447684A (zh) * | 2000-06-16 | 2003-10-08 | 特瓦制药工业有限公司 | 具有在可控制范围内的pH值的稳定的加巴喷丁 |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
US20040185097A1 (en) * | 2003-01-31 | 2004-09-23 | Glenmark Pharmaceuticals Ltd. | Controlled release modifying complex and pharmaceutical compositions thereof |
-
2004
- 2004-11-10 DK DK04810659T patent/DK1729735T3/da active
- 2004-11-10 AU AU2004324858A patent/AU2004324858B2/en not_active Expired - Fee Related
- 2004-11-10 CA CA002587295A patent/CA2587295A1/en not_active Abandoned
- 2004-11-10 PT PT04810659T patent/PT1729735E/pt unknown
- 2004-11-10 AT AT04810659T patent/ATE365546T1/de not_active IP Right Cessation
- 2004-11-10 EP EP04810659A patent/EP1729735B1/en active Active
- 2004-11-10 WO PCT/US2004/037462 patent/WO2006052254A2/en active Application Filing
- 2004-11-10 JP JP2007541148A patent/JP4842960B2/ja active Active
- 2004-11-10 DE DE602004007302T patent/DE602004007302T2/de active Active
-
2007
- 2007-04-15 IL IL182549A patent/IL182549A/en active IP Right Grant
- 2007-04-27 HK HK07104564A patent/HK1096875A1/xx not_active IP Right Cessation
-
2009
- 2009-08-18 IL IL200447A patent/IL200447A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1096875A1 (en) | 2007-06-15 |
IL200447A0 (en) | 2011-07-31 |
EP1729735B1 (en) | 2007-06-27 |
ATE365546T1 (de) | 2007-07-15 |
EP1729735A2 (en) | 2006-12-13 |
AU2004324858A1 (en) | 2006-05-18 |
AU2004324858B2 (en) | 2009-12-10 |
PT1729735E (pt) | 2007-08-06 |
DE602004007302D1 (de) | 2007-08-09 |
IL182549A (en) | 2010-11-30 |
DE602004007302T2 (de) | 2008-03-20 |
CA2587295A1 (en) | 2006-05-18 |
JP4842960B2 (ja) | 2011-12-21 |
JP2008519834A (ja) | 2008-06-12 |
IL182549A0 (en) | 2007-09-20 |
WO2006052254A2 (en) | 2006-05-18 |
WO2006052254A3 (en) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004056363A3 (en) | A physically and chemically stable nicotine-containing particulate material | |
WO2009043844A3 (en) | Orodispersible tablets | |
WO2004012700A3 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
RU2008106220A (ru) | Гастроретентивные композиции и способ их изготовления | |
WO2004050058A3 (en) | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base | |
WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
NZ527585A (en) | Tablets quickly disintegrated in oral cavity | |
WO2006100281A3 (en) | Solubilized ibuprofen | |
AR062509A1 (es) | Proceso para preparar comprimidos de dihidrocloruro de pramipexol | |
HK1072359A1 (en) | Pharmaceutical composition comprising N-((1-N-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-A)indole-10carboxamide or salt and process for preparing thereof comprising dry granulation | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
WO2006082501A3 (en) | Fast wet-massing method for the preparation of calcium-containing compositions | |
HK1038699B (zh) | 製備氟苯哌苯醚固體分散體的水性方法 | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
WO2008100240A3 (en) | Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same | |
IL200447A0 (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
RU2006145311A (ru) | Твердая фармацевтическая композиция | |
EA200500671A1 (ru) | Фармацевтический состав оланзапина | |
RU2007133793A (ru) | Составы с контролируемым высвобождением альфузозина | |
WO2008084676A1 (ja) | 多孔性乾燥マトリックスの医薬組成物 | |
RU2016106328A (ru) | Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления | |
WO2006081779A3 (en) | A pharmaceutical composition containing olanzapine as the active agent and a process for the preparation thereof |